Skip to main content
TipRanks
Go Ultimate75% OFF

Chemomab Therapeutics (2QV) Q1 2026 Earnings Report

1 Followers

DE:2QV Q1 2026 EPS Results

Actual EPS
EUR 0.00
Consensus EPS
EUR 0.00
Beat/Miss
Missed by -EUR 0.00
One Year Ago EPS
-EUR 0.03

DE:2QV Q1 2026 Revenue Results

Actual Revenue
EUR 0
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q1 2026
Date
05/14/2026
Time
Before Open
Conference Call
Thursday, May 14, 2026
DE:2QV Upcoming Earnings

Chemomab Therapeutics's next earnings date is estimated for March 10, 2027, based on past reporting schedules.

Q1 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q1 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:2QV Earnings History

DE:2QV earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 10, 20272026 (Q4)―-0――
Nov 19, 20262026 (Q3)0.00-0.01-0.0150.00% (+0.01)
Aug 19, 20262026 (Q2)-0.14-0.00-0.0181.25% (+0.01)
May 14, 20262026 (Q1)0.00-0.00-0.0389.29% (+0.02)
Mar 19, 20262025 (Q4)-0.04-0.00-0.0390.63% (+0.03)
Nov 20, 20252025 (Q3)-0.04-0.01-0.0460.00% (+0.02)
Aug 14, 20252025 (Q2)-0.04-0.01-0.0569.23% (+0.03)
May 15, 20252025 (Q1)-0.04-0.03-0.0550.00% (+0.03)
Mar 03, 20252024 (Q4)-0.04-0.03-0.0538.46% (+0.02)
Nov 14, 20242024 (Q3)-0.04-0.04-0.0641.18% (+0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed